Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-15

Clinical Trial Update: Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema) [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial of Tofacitinib ointment for atopic dermatitis and posted the results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib Ointment (Tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2015-10-15